SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-023230
Filing Date
2021-04-28
Accepted
2021-04-28 13:31:43
Documents
3
Period of Report
2021-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140034-8k_inmedpharma.htm 8-K 30058
2 NEWS RELEASE, DATED APRIL 28, 2021 ea140034ex99-1_inmedpharma.htm EX-99.1 19410
3 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
  Complete submission text file 0001213900-21-023230.txt   73831
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21863099
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences